65996-07-8 Usage
Uses
Used in Pharmaceutical Industry:
2-Bromo-4-methyl-nicotinic acid is used as a building block for the synthesis of bioactive molecules, contributing to the development of new drugs with potential therapeutic effects. Its unique structure allows for the creation of compounds that can target specific enzymes and receptors, enhancing drug efficacy and selectivity.
Used in Agrochemical Industry:
2-Bromo-4-methyl-nicotinic acid is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its ability to inhibit specific enzymes and receptors in pests and weeds can lead to the development of more effective and targeted agrochemicals, reducing environmental impact and increasing crop yield.
Used in Drug Discovery and Development:
2-Bromo-4-methyl-nicotinic acid is used as a valuable target for drug discovery and development due to its potential as an enzyme and receptor inhibitor. Its unique structure allows for the design of compounds with high specificity and affinity, leading to the development of more effective drugs with fewer side effects.
Used in Research and Development:
2-Bromo-4-methyl-nicotinic acid is used as an interesting compound for further research and potential applications in various fields. Its unique structure and properties make it a promising candidate for the exploration of new chemical reactions, synthesis methods, and applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 65996-07-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,9,9 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 65996-07:
(7*6)+(6*5)+(5*9)+(4*9)+(3*6)+(2*0)+(1*7)=178
178 % 10 = 8
So 65996-07-8 is a valid CAS Registry Number.
65996-07-8Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00548, (2013/03/26)
Compounds and pharmaceutical compositions of formulae (I), (XI) and (XII) as PI3 kinase modulators and their use in the treatment of diseases such as cancer.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00720; 00790, (2013/03/26)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
Chemokine receptor binding compounds
-
Page/Page column 28, (2008/06/13)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds
